Moreover, the network shows the importance of MZB1, which may be involved in MS pathology through activating autoproliferative CD4+ T cells and pathogenic B cells in CSF and is thought to potentially trigger B cell response against Epstein–Barr virus (EBV) proteins67. Here, CD4 is linked to myeloid sarcoma.